RecallRadar

FDA Drug recall D-1169-2017

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven…

On 2017-09-27 the FDA classified a Class II recall of Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven… by Noven Pharmaceuticals, citing defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1169-2017
ClassificationClass II
Statusterminated
Initiated2017-08-30
Published2017-09-27
Last updated2026-09-13 11:51 UTC
CompanyNoven Pharmaceuticals
DistributionUS

Product

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Rx Only Contains: 30 Patches Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5552-3

Reason

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Identifiers

ndc68968-5552-3
ndc68968-5553-3
ndc68968-5554-3
ndc68968-5555-3
code_infoLot: 80433 Exp. 08/17

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1169-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.